Shared Decision-making and Antimicrobial Stewardship in Secondary Care (SHARE)

May 29, 2025 updated by: Royal Cornwall Hospitals Trust

Shared Decision-making and Antimicrobial Stewardship in Secondary Care: Exploring Opportunities Along the Start Smart Then Focus Patient Pathway

To identify opportunities for antibiotic prescribing shared decision making between patients and prescribers in secondary care.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This is a qualitative study with patients and clinicians in secondary care.

We will use semi-structured interviews with patients and clinicians to address the research question. Patients that have received antibiotics during a recent inpatient stay will be identified using the hospital electronic prescribing system and a letter inviting study participation will be included in their discharge medication pack. Senior prescribing decision makers will be recruited from participating hospitals. In total, we hope to carry out up to 50 interviews with patients and clinicians.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United Kingdom
      • Truro, United Kingdom, TR1 3LJ
        • Recruiting
        • Chelsea and Westminster Hospital
        • Contact:
        • Principal Investigator:
          • Stephen Hughes, Pharmacist
    • Cornwall
      • Truro, Cornwall, United Kingdom, TR1 3LJ
        • Recruiting
        • Royal Cornwall Hospital
        • Contact:
        • Principal Investigator:
          • Neil Powell, Pharmacist

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

We will use semi-structured interviews with patients and clinicians to address the research question. Patients that have received antibiotics during a recent inpatient stay will be identified using the hospital electronic prescribing system and a letter inviting study participation will be included in their discharge medication pack. Senior prescribing decision makers will be recruited from participating hospitals.

Description

Inclusion Criteria:

For clinicians:

  • Participant is willing and able to give informed consent for participation in the study.
  • Senior registrar or consultant medical or surgical doctor working at participating hospitals and caring for inpatients.
  • Fluent in English.

For patients:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 16 years or above (no upper age limit).
  • Good standard of speaking English and able to read and understand study materials.
  • Received antibiotic for treatment of suspected or confirmed bacterial infection during inpatient stay.

Exclusion Criteria:

  • For clinicians:

    • Prescribers not currently caring for inpatients

For patients:

• Patient who received prophylaxis antibiotics only

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients
Other: None - Interview Only
None - Interview Only
Healthcare workers
Other: None - Interview Only
None - Interview Only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient and prescriber views and experiences with shared decision making (SDM) around antibiotic prescribing in secondary care and to identify further opportunities for SDM.
Time Frame: 1 year
Data will be analysed using thematic analysis
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Royal Cornwall Hospitals Trust

Collaborators

University of Oxford

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2024

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

September 18, 2024

First Submitted That Met QC Criteria

September 18, 2024

First Posted (Actual)

September 20, 2024

Study Record Updates

Last Update Posted (Actual)

June 4, 2025

Last Update Submitted That Met QC Criteria

May 29, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2023.RCHT.05

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Antibiotic Prescribing is the Study Focus (no Condition)

Clinical Trials on None - Interview Only

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe